Atypical Hemolytic Uremic Syndrome (Nondiarrhea-Associated Hemolytic Uremic Syndrome) Therapeutic Pipeline Drugs and Companies Review H1 2015
The report "Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome). Atypical hemolytic-uremic syndrome is a disease that primarily affects kidney function. Atypical hemolytic-uremic syndrome is caused by a genetic deficiency in one or more of the complement regulatory genes, which causes chronic uncontrolled complement activation. Atypical hemolytic-uremic syndrome is characterized by three major features related to abnormal...
View full press release